Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Study Information
Alliance Study ID: NCCTG-963251
NCT Study ID (ClinicalTrials.gov): NCT00002998
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Patrick A. Burch, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine and cisplatin in treating patients with metastatic breast cancer that has not responded to systemic therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information